Department of Radiology, The 1st Affiliated Hospital of Chinese PLA General Hospital, Beijing 100048, China.
Department of Radiology, Chinese PLA 95th Hospital, Putian, Fujian 351100, China.
Chin Med J (Engl). 2017 Nov 5;130(21):2591-2600. doi: 10.4103/0366-6999.217089.
Biotherapy based on human bone marrow-derived mesenchymal stem cells (BMSCs) is currently the focus of research, especially in the field of autologous stem cell transplantation. A novel type of metastasis-associated magnetic resonance (MR) molecular imaging probe was constructed, and the changes in metastasis and proliferation of hepatocellular carcinoma (HCC) before and after BMSC intervention were observed through MR imaging (MRI).
Metastasis-associated MR molecular imaging probe, integrin αvβ3ligand cRGD-PEG-DGL-DTPA-Gd (Gd-RGD), were constructed. After human BMSC intervention was performed for 6 weeks, tumor weight inhibition rates were calculated, and the RGD molecular probe was imaged through MRI with molecular imaging agent Gd-DTPA as control. The signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) in the MRI experiment were used as semi-quantitative indicators. Polymerase chain reaction method was performed to detect proliferation- and metastasis-associated indicators, transforming growth factor β-1 (TGFβ1), osteopontin (OPN), and integrin subunit αvand β3.
The highest tumor weight inhibition rates were observed 3 weeks after the BMSC transplantation. The MR Gd-RGD in the HCC tissues after the BMSC intervention showed less enhancement than Gd-DTPA. The Gd-DTPA MRI of control group had higher SNR and CNR than Gd-RGD MRI in the experimental groups (P < 0.05). For high metastatic potential hepatocellular carcinoma (MHCC97-H), significant differences were observed in the SNRs and CNRs of Gd-RGD MRI before and after the BMSC intervention (P < 0.05). For low metastatic potential hepatocellular carcinoma (MHCC97-L), the CNRs of Gd-RGD MRI were statistically different before and after BMSC intervention (P < 0.05). With regard to MHCC97-H, OPN, β3, and TGFβ1 expression significantly decreased after BMSC intervention (P < 0.05). In MHCC97-L and OPN, β3, TGFβ1, and αv expression after BMSC intervention decreased, and the difference was statistically significant (P < 0.05).
The CNR index of MRI is a good indicator for distinguishing high- and low-metastatic potential HCC tissues. After BMSC transplantation of MRI through the two kinds of tracer, the SNR and CNR indexes can distinguish two kinds of high and low metastatic potential HCC tissues, and Gd-RGD imaging is more suitable in distinguishing the metastatic potential changes through BMSC intervention.
基于人骨髓间充质干细胞(BMSCs)的生物治疗目前是研究的焦点,尤其是在自体干细胞移植领域。构建了一种新型的转移相关磁共振(MR)分子成像探针,通过磁共振成像(MRI)观察 BMSC 干预前后肝癌(HCC)转移和增殖的变化。
构建转移相关的 MR 分子成像探针,整合素αvβ3配体 cRGD-PEG-DGL-DTPA-Gd(Gd-RGD)。BMSC 干预 6 周后计算肿瘤重量抑制率,并用分子成像剂 Gd-DTPA 作为对照对 RGD 分子探针进行 MRI 成像。MRI 实验中的信噪比(SNR)和对比噪声比(CNR)用作半定量指标。采用聚合酶链反应法检测增殖和转移相关指标转化生长因子β-1(TGFβ1)、骨桥蛋白(OPN)和整合素亚基αv和β3。
BMSC 移植后 3 周观察到最高的肿瘤重量抑制率。BMSC 干预后的 HCC 组织中的 MR Gd-RGD 增强程度低于 Gd-DTPA。对照组 Gd-DTPA 的 MRI 的 SNR 和 CNR 均高于实验组 Gd-RGD 的 MRI(P <0.05)。对于高转移潜能肝癌(MHCC97-H),BMSC 干预前后 Gd-RGD MRI 的 SNR 和 CNR 差异有统计学意义(P <0.05)。对于低转移潜能肝癌(MHCC97-L),BMSC 干预前后 Gd-RGD MRI 的 CNR 差异有统计学意义(P <0.05)。对于 MHCC97-H,BMSC 干预后 OPN、β3 和 TGFβ1 表达显著降低(P <0.05)。在 MHCC97-L 和 OPN、β3、TGFβ1 和αv中,BMSC 干预后表达降低,差异有统计学意义(P <0.05)。
MRI 的 CNR 指数是区分高转移潜能和低转移潜能 HCC 组织的良好指标。通过两种示踪剂进行 BMSC 移植后的 MRI,SNR 和 CNR 指数可区分两种高转移潜能和低转移潜能的 HCC 组织,Gd-RGD 成像更适合于通过 BMSC 干预来区分转移潜能的变化。